Amanote Research
Register
Sign In
OS7 - 145 Combination Immunotherapy for Glioma: Beyond PD 1 Inhibition
Canadian Journal of Neurological Sciences
- United Kingdom
doi 10.1017/cjn.2016.338
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Neurology
Date
October 1, 2016
Authors
W. Curry
Publisher
Cambridge University Press (CUP)
Related search
Beyond PD-1 Immunotherapy in Malignant Melanoma
Dermatology and Therapy
Dermatology
PAK4 Inhibition Improves PD-1 Blockade Immunotherapy
Nature Cancer
Triple Combination Immunotherapy With GVAX, Anti-Pd-1 Monoclonal Antibody, and Agonist Anti-Ox40 Monoclonal Antibody Is Highly Effective Against Murine Intracranial Glioma
OncoImmunology
Oncology
Allergy
Immunology
Tumor Immunotherapy Directed at PD-1
New England Journal of Medicine
Medicine
Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)
Advanced Materials
Mechanics of Materials
Materials Science
Nanotechnology
Mechanical Engineering
Nanoscience
Combination Immunotherapy for Melanoma
JAMA Oncology
Cancer Research
Oncology
Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy
Oncolytic Virotherapy
Combination Cancer Immunotherapy Targeting PD-1 and GITR Can Rescue CD8+ T Cell Dysfunction and Maintain Memory Phenotype
Science immunology
Allergy
Immunology
Blocking the PD-1/PD-L1 Pathway in Glioma: A Potential New Treatment Strategy
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
